Axberi Hp 150 mg (Enoxaparin Sodium SOLUTION) 150 MG

AXBERI HP 150 MG is an intravenous solution containing enoxaparin sodium, used for anticoagulation therapy. This medication helps prevent blood clots in various medical conditions.

Strength

150 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AXBERI HP 150 MG is primarily used for anticoagulation, which involves thinning the blood to prevent clots. It is often prescribed for conditions like deep vein thrombosis (DVT) or during certain medical procedures to reduce the risk of clot formation. The solution is administered intravenously, making it suitable for hospital settings where close monitoring is possible.

Side Effects

Common effects of AXBERI HP 150 MG may include bruising or bleeding at the injection site. Some individuals might experience mild pain or irritation. Severe side effects are rare but can include unusual bleeding or bruising, which should be reported to a healthcare provider immediately.

Precautions & Warnings

AXBERI HP 150 MG should be handled with care to avoid contamination. It is essential to follow proper administration procedures to minimize the risk of infection or other complications. Patients with a history of bleeding disorders or allergies to enoxaparin sodium should consult their healthcare provider before use.

Avoid Interactions

AXBERI HP 150 MG may interact with other medications that affect blood clotting, such as aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs). It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may increase the risk of bleeding.

Frequently Asked Questions

AXBERI HP 150 MG is used for anticoagulation to prevent blood clots in various medical conditions.

AXBERI HP 150 MG is administered intravenously, typically in a hospital setting.

Common side effects may include bruising or bleeding at the injection site, mild pain, or irritation.

AXBERI HP 150 MG may interact with other medications that affect blood clotting, so it is important to consult a healthcare provider.

Patients with a history of bleeding disorders or allergies to enoxaparin sodium should consult their healthcare provider before using AXBERI HP 150 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.